Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI
10.1371/journal.pone.0147681
Saved in:
Main Authors: | Lee L.S.-U., Seng K.-Y., Wang L.-Z., Yong W.-P., Hee K.-H., Soh T.I., Wong A., Cheong P.F., Soong R., Sapari N.S., Soo R., Fan L., Lee S.-C., Goh B.C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142618 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Raltegravir pharmacokinetics during pregnancy
by: D. Heather Watts, et al.
Published: (2018) -
Raltegravir pharmacokinetics during pregnancy
by: D. Heather Watts, et al.
Published: (2018) -
Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1
by: Wang, L, et al.
Published: (2020) -
Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
by: Jada, S.R., et al.
Published: (2011) -
Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers
by: Wang, L., et al.
Published: (2014)